
CERVICAL CANCER AND HUMAN PAPILLOMAVIRUS Grce M* *Corresponding Author: Dr. sc. Magdalena Grce, Rudjer Boskovic Institute, Laboratory of Molecular Virology and Bacteriology, Division of Molecular Medicine, Bijenicka 54, HR-10002 Zagreb, Croatia; Tel.: +385-1-4561110; Fax: +385-1-4561010; E-mail: grce@irb.hr page: 19
|
OTHER FACTORS IN CERVICAL CAN¬CER CARCINOGENESIS
Among HPV-positive women, any use of oral contraceptives was associated with a significant increase in risk of cervical carcinogenesis (OR = 1.47); use for less than 5 years was not related to the development of cervical cancer (OR = 0.77), but the risk increased significantly for 5-9 years of use (OR = 2.72) and for 10 or more years of use (OR = 4.48) [13]. A recent meta-analysis confirmed the interaction between the use of oral contraceptives and HPV infection in the risk of cervical cancer, particularly for prolonged periods [14]. These findings strongly suggest either that steroid hormones interact with HPV in the cervical carcinogenesis or that women using oral contraceptives are more prone to hazardous sexual activity that leads to HPV infection.
High parity is a risk factor for cervical cancer. Human papillomavirus-positive women who reported seven or more full-term pregnancies had a 4-fold increased risk of cervical cancer as compared to similar HPV-positive women who were nulliparous (OR = 3.8) [8].
Smoking was associated with a 2-fold statistically significant increased risk of cervical cancer with a significant dose response, and is an independent risk factor for cervical cancer [15].
Some sexually transmitted infections (herpes simplex virus type 2, human immunodeficiency virus and non specific infection) have repeatedly been found to be associated with cervical cancer [8]. Thus, there is a 2-fold increased risk for the presence of antibodies to Chlamydia trachomatis (OR = 2.1) [8]. Other environmental risk factors, such as socioeconomic status and nutritional factors that are in favor of the spread and the maintenance of sexually transmitted infections, are under evaluation [1].
Although studies in males are rarer, there is consistent evidence that circumcision protects against persistent HPV infection and subsequent cervical cancer development in partners [16]. Furthermore, even though condom use does not protect against all HPV infections, it does promote regression of CIN and clearance of HPV infection [17].
|
|
|
|



 |
Number 27 VOL. 27 (2), 2024 |
Number 27 VOL. 27 (1), 2024 |
Number 26 Number 26 VOL. 26(2), 2023 All in one |
Number 26 VOL. 26(2), 2023 |
Number 26 VOL. 26, 2023 Supplement |
Number 26 VOL. 26(1), 2023 |
Number 25 VOL. 25(2), 2022 |
Number 25 VOL. 25 (1), 2022 |
Number 24 VOL. 24(2), 2021 |
Number 24 VOL. 24(1), 2021 |
Number 23 VOL. 23(2), 2020 |
Number 22 VOL. 22(2), 2019 |
Number 22 VOL. 22(1), 2019 |
Number 22 VOL. 22, 2019 Supplement |
Number 21 VOL. 21(2), 2018 |
Number 21 VOL. 21 (1), 2018 |
Number 21 VOL. 21, 2018 Supplement |
Number 20 VOL. 20 (2), 2017 |
Number 20 VOL. 20 (1), 2017 |
Number 19 VOL. 19 (2), 2016 |
Number 19 VOL. 19 (1), 2016 |
Number 18 VOL. 18 (2), 2015 |
Number 18 VOL. 18 (1), 2015 |
Number 17 VOL. 17 (2), 2014 |
Number 17 VOL. 17 (1), 2014 |
Number 16 VOL. 16 (2), 2013 |
Number 16 VOL. 16 (1), 2013 |
Number 15 VOL. 15 (2), 2012 |
Number 15 VOL. 15, 2012 Supplement |
Number 15 Vol. 15 (1), 2012 |
Number 14 14 - Vol. 14 (2), 2011 |
Number 14 The 9th Balkan Congress of Medical Genetics |
Number 14 14 - Vol. 14 (1), 2011 |
Number 13 Vol. 13 (2), 2010 |
Number 13 Vol.13 (1), 2010 |
Number 12 Vol.12 (2), 2009 |
Number 12 Vol.12 (1), 2009 |
Number 11 Vol.11 (2),2008 |
Number 11 Vol.11 (1),2008 |
Number 10 Vol.10 (2), 2007 |
Number 10 10 (1),2007 |
Number 9 1&2, 2006 |
Number 9 3&4, 2006 |
Number 8 1&2, 2005 |
Number 8 3&4, 2004 |
Number 7 1&2, 2004 |
Number 6 3&4, 2003 |
Number 6 1&2, 2003 |
Number 5 3&4, 2002 |
Number 5 1&2, 2002 |
Number 4 Vol.3 (4), 2000 |
Number 4 Vol.2 (4), 1999 |
Number 4 Vol.1 (4), 1998 |
Number 4 3&4, 2001 |
Number 4 1&2, 2001 |
Number 3 Vol.3 (3), 2000 |
Number 3 Vol.2 (3), 1999 |
Number 3 Vol.1 (3), 1998 |
Number 2 Vol.3(2), 2000 |
Number 2 Vol.1 (2), 1998 |
Number 2 Vol.2 (2), 1999 |
Number 1 Vol.3 (1), 2000 |
Number 1 Vol.2 (1), 1999 |
Number 1 Vol.1 (1), 1998 |
|
|